Search Within

Michael Morris

  1. "Anuradha Gopalan"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (8)
Groups
  1. Department of Medicine (22)
  2. Department of Pathology and Laboratory Medicine (22)
  3. Genitourinary Oncology Service (22)
  4. Solid Tumor Oncology Division (22)
  5. GSK Faculty (20)
  6. Human Oncology and Pathogenesis Program (20)

More Groups

People
  1. Anuradha Gopalan (22)
  2. Howard Scher (17)
  3. Dana Rathkopf (15)
  4. Wassim Abida (15)
  5. Charles Sawyers (12)
  6. Nikolaus Schultz (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (4)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cell (3)
  3. Cancer Research (2)
  4. European Urology (2)
  5. Cell Reports (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Cell Press (4)
  3. American Association for Cancer Research (3)
  4. Nature Publishing Group (3)
  5. Elsevier Science, Inc. (2)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Microsatellite instability, tumor mutational burden, and response to immune checkpoint blockade in patients with prostate cancer
    Journal Article

    Lenis, A. T.; Ravichandran, V.; Brown, S.; Alam, S. M.; Katims, A.; Truong, H.; Reisz, P. A.; Vasselman, S.; Nweji, B.; Autio, K. A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies
    Journal Article

    Zaidi, S.; Park, J.; Chan, J. M.; Roudier, M. P.; Zhao, J. L.; Gopalan, A.; Wadosky, K. M.; Patel, R. A.; Sayar, E.; Karthaus, W. R.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2024)

    Fulltext@MSK | Save
  • Effect of Janus kinase (JAK) signaling inhibition on lineage plasticity and drug sensitivity in castrate resistant prostate cancer
    Meeting Abstract

    Zaidi, S.; Chan, J. M.; Love, J.; Zhao, J.; Setty, M.; Lawrence, K.; Gopalan, A.; Goodrich, D.; Morris, M. J.; Chen, Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Multilineage plasticity in prostate cancer through expansion of stem-like luminal epithelial cells with elevated inflammatory signaling
    Meeting Abstract

    Zaidi, S.; Zhao, J.; Chan, J.; Martine, R.; Wadosky, K.; Gopalan, A.; Karthaus, W.; Watson, P.; True, L.; Nelson, P.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
    Meeting Abstract

    Chan, J.; Zaidi, S.; Love, J.; Zhao, J.; Setty, M.; Wadosky, K.; Gopalan, A.; Choo, Z. N.; Persad, S.; Chaudhary, O.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
    Journal Article

    Chan, J. M.; Zaidi, S.; Love, J. R.; Zhao, J. L.; Setty, M.; Wadosky, K. M.; Gopalan, A.; Choo, Z. N.; Persad, S.; Choi, J.; more...
    Science (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • CDK12 alterations define a distinct molecular subtype of prostate cancers with unique genomic and clinical characteristics
    Meeting Abstract

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H.; Kantoff, P. W.; Gopalan, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save